Stocks · Healthcare · Drug Manufacturers - General
Eli Lilly and Company LLY
$1,142.85 -0.61% Close, Oct 2, 2026 · NYSE · Market cap $1.08T
Strong growthHigh qualityLow risk
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $29.80, up 94.8% year over year.
- Revenue over the last four quarters was $79.67B, up 49.6% from a year earlier, accelerating from 47.4% a quarter earlier.
- The shares trade at 38.4× trailing earnings, lower than 95% of the company's own readings over the past five years.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth94Exceptional
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 18%
- EPS growth (TTM, YoY)Top 14%
- Revenue growth, 3-year CAGRTop 20%
- Revenue growth accelerationTop 27%
Quality88Strong
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 2%
- Gross marginTop 26%
- Operating marginTop 1%
- Cash conversion (OCF / net income)Bottom 24%
- Accruals (lower is better)Bottom 19%
- Net debt / EBITDA (lower is better)Top 48%
- Interest coverTop 6%
Value76Positive
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 21%
- Free-cash-flow yieldTop 30%
- EBITDA / enterprise valueTop 28%
- Sales / enterprise valueBottom 25%
- P/E vs own 5-year history (lower is better)Top 15%
Momentum72Positive
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 38%
- 6-month returnTop 38%
- 1-year return vs S&P 500Top 31%
- Distance from 52-week highTop 18%
- Trend checklist (0–4)Top 39%
Revisions75Positive
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 22%
- Consecutive EPS beatsTop 10%
- Share of analysts rating BuyBottom 44%
- Upside to consensus price targetBottom 25%
Stability94Exceptional
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 8%
- Maximum drawdown, 3 yearsTop 8%
- Beta vs S&P 500 (lower is better)Top 15%
- Net debt / EBITDA (lower is better)Top 48%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 47.4% | 49.6% | ↑ |
| EPS growth (YoY) | 129.0% | 94.8% | ↓ |
| Gross margin | 82.6% | 83.4% | ↑ |
| Operating margin | 42.1% | 49.7% | ↑ |
| FCF margin | -0.1% | 25.2% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 49.6% | 47.4% | ↑ | Top 18% |
| EPS growth (TTM, YoY) | 94.8% | 129.0% | ↓ | Top 14% |
| Gross margin | 83.4% | 82.6% | ↑ | Top 26% |
| Operating margin | 49.7% | 42.1% | ↑ | Top 1% |
| Net margin | 33.5% | 25.9% | ↑ | — |
| Free-cash-flow margin | 25.2% | -0.1% | ↑ | — |
| Return on invested capital | 31.0% | — | Top 2% | |
| Revenue growth, 3-year CAGR | 31.7% | — | Top 20% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.05×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -1.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -13.1 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.06×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 40.4×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.54%
- Net buyback yield (TTM)
- 0.57%
- Shareholder yield
- 1.11%
- Share count change, 1 year
- -0.7%
- Share count change, 3-year CAGR
- -2.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 7
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +21.5%
- Average 2-day reaction, last 8
- +0.0%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $1,343.07
- Target vs current price
- +17.5%
- Analysts with a rating
- 45
- Share rating Buy or Strong Buy
- 73%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +30.9% | +4.9% | +8.9% | +4.0% | — |
| Apr 30, 2026 | +22.7% | +9.8% | +16.0% | +32.4% | +40.7% |
| Feb 4, 2026 | +9.1% | +10.3% | +2.1% | +0.0% | -6.9% |
| Oct 30, 2025 | +23.4% | +3.8% | +13.8% | +35.7% | +27.8% |
| Aug 7, 2025 | +12.7% | -14.1% | -11.5% | -0.5% | +13.1% |
| May 1, 2025 | +2.5% | -11.7% | -13.6% | -19.6% | -10.1% |
| Feb 6, 2025 | +5.8% | +3.3% | +3.7% | +8.4% | -2.2% |
| Oct 30, 2024 | -19.7% | -6.3% | -10.8% | -12.6% | -10.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | $8.38 | $6.40 | +30.9% | $22.97B |
| Apr 30, 2026 | $8.55 | $6.97 | +22.7% | $19.80B |
| Feb 4, 2026 | $7.54 | $6.91 | +9.1% | $19.29B |
| Oct 30, 2025 | $7.02 | $5.69 | +23.4% | $17.60B |
| Aug 7, 2025 | $6.31 | $5.60 | +12.7% | $15.56B |
| May 1, 2025 | $3.34 | $3.26 | +2.5% | $12.73B |
| Feb 6, 2025 | $5.32 | $5.03 | +5.8% | $13.53B |
| Oct 30, 2024 | $1.18 | $1.47 | -19.7% | $11.44B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 38.4× | 50.8× | 5th | Top 21% |
| P/E (forward) | 31.2× | — | — | — |
| EV / EBITDA | 25.9× | — | — | Top 28% |
| EV / Sales | 14.09× | — | — | Bottom 25% |
| Free-cash-flow yield | 1.86% | — | — | Top 30% |
| Earnings yield | 2.61% | — | — | Top 21% |
P/E over the past five years
Range 33.2× – 132.3× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +38.5%
- Earnings per share growth (TTM)
- +94.8%
- Change in P/E multiple
- -6.3%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 108
- 50-day average slope (20 days)
- -1.2%
- 200-day average slope (20 days)
- +1.0%
- Distance from 50-day average
- -2.9%
- Distance from 200-day average
- +6.4%
- RSI (14)
- 43.0
- Relative volume
- 0.90×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 29.5%
- Volatility vs own 5-year history
- 41th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.47
- Correlation with S&P 500
- 0.18
- Current drawdown from 1-year high
- -10.7%
- Maximum drawdown, 3 years
- -34.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Aug 30, 2024 | Aug 8, 2025 | -34.8% | 234 days | 65 days (Nov 10, 2025) |
| Nov 25, 2025 | Apr 29, 2026 | -23.3% | 105 days | 20 days (May 28, 2026) |
| Jul 15, 2024 | Aug 7, 2024 | -18.8% | 17 days | 10 days (Aug 21, 2024) |
| Aug 17, 2021 | Sep 28, 2021 | -18.7% | 29 days | 55 days (Dec 15, 2021) |
| Dec 2, 2022 | Mar 7, 2023 | -17.1% | 63 days | 26 days (Apr 13, 2023) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.08T
- P/E (TTM)
- 38.4
- EPS, diluted (TTM)
- $29.80
- Revenue (TTM)
- $79.67B
- Dividend yield
- 0.59%
- 52-week range
- $783.85 – $1,292.65
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $28.32B | $28.54B | $34.12B | $45.04B | $65.18B |
| Gross profit | $21.01B | $21.91B | $27.04B | $36.63B | $54.13B |
| Operating income | $7.93B | $8.65B | $10.79B | $17.04B | $29.70B |
| Net income | $5.58B | $6.24B | $5.24B | $10.59B | $20.64B |
| EPS (diluted) | $5.85 | $6.57 | $5.80 | $11.71 | $22.95 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.44B | $13.53B | $12.73B | $15.56B | $17.60B | $19.29B | $19.80B | $22.97B |
| Net income | $970.3M | $4.41B | $2.76B | $5.66B | $5.58B | $6.64B | $7.40B | $7.09B |
| EPS (diluted) | $1.07 | $4.88 | $3.06 | $6.29 | $6.21 | $7.39 | $8.26 | $7.94 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $7.37B | $7.59B | $4.24B | $8.82B | $16.81B |
| Capital expenditure | -$1.98B | -$2.99B | -$7.39B | -$8.40B | -$7.84B |
| Free cash flow | $5.39B | $4.60B | -$3.15B | $414.3M | $8.97B |
| Dividends paid | -$3.09B | -$3.54B | -$4.07B | -$4.68B | -$5.38B |
| Net share buybacks | -$1.25B | -$1.50B | -$750.0M | -$2.50B | -$4.11B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $8.95B
- Total assets
- $142.28B
- Total liabilities
- $108.40B
- Total debt
- $54.91B
- Net debt
- $46.02B
- Shareholders’ equity
- $33.88B
As of Jun 30, 2026 (filed Aug 5, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 14, 2026 | $1.73 | Sep 10, 2026 |
| May 15, 2026 | $1.73 | Jun 10, 2026 |
| Feb 13, 2026 | $1.73 | Mar 10, 2026 |
| Nov 14, 2025 | $1.50 | Dec 10, 2025 |
| Aug 15, 2025 | $1.50 | Sep 10, 2025 |
| May 16, 2025 | $1.50 | Jun 10, 2025 |
| Feb 14, 2025 | $1.50 | Mar 10, 2025 |
| Nov 15, 2024 | $1.30 | Dec 10, 2024 |
Short interest
- Shares sold short
- 7,519,918
- Days to cover
- 3.41
- Change vs previous report
- -4.7%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Oct 16, 1997
- 2-for-1
- Dec 21, 1995
- 2-for-1
- May 1, 1989
- 2-for-1
- Jan 30, 1986
- 2-for-1